Taha, Mohamad B.
Yahya, Tamer
Satish, Priyanka
Laird, Rachel
Agatston, Arthur S.
Cainzos-Achirica, Miguel
Patel, Kershaw V.
Nasir, Khurram
Article History
Accepted: 11 April 2022
First Online: 28 May 2022
Declarations
:
: Dr. Nasir is on the advisory board of Amgen, Novartis, and Medicine Company, and his research is partly supported by the Jerold B. Katz Academy of Translational Research. No other conflicts of interest relevant to the content of this manuscript were reported by the authors.
: This article does not contain any studies with human or animal subjects performed by any of the authors.